These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7191834)

  • 1. [Tolerance of beta-propiolactone-treated and UV-irradiated rat serum].
    Sonneborn HH; Stephan W
    Infusionsther Klin Ernahr; 1980 Jun; 7(3):145-7. PubMed ID: 7191834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunogenicity of the rabies virus treated with phenol, beta-propiolactone and heat].
    Sazanova EIa; Kuznetsova SV; Kuznetsov PP; Ivanov VS
    Veterinariia; 1980 Mar; (3):32-3. PubMed ID: 7395053
    [No Abstract]   [Full Text] [Related]  

  • 3. Long-term tolerance and recovery of beta-propiolactone/ultraviolet (beta PL/UV) treated PPSB in chimpanzees.
    Stephan W; Kotitschke R; Prince AM; Brotman B
    Thromb Haemost; 1981 Aug; 46(2):511-4. PubMed ID: 7302890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgE and IgG antibodies to beta-propiolactone and human serum albumin associated with urticarial reactions to rabies vaccine.
    Swanson MC; Rosanoff E; Gurwith M; Deitch M; Schnurrenberger P; Reed CE
    J Infect Dis; 1987 May; 155(5):909-13. PubMed ID: 3559291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of thrombogenicity of beta-propiolactone/ultraviolet (beta-PL/UV) treated PPSB in chimpanzees.
    Kotitschke R; Stephan W; Prince AM; Brotman B
    Thromb Res; 1983 May; 30(3):235-44. PubMed ID: 6868023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver-associated lymphocytes expressing NK1.1 are essential for oral immune tolerance induction in a murine model.
    Trop S; Samsonov D; Gotsman I; Alper R; Diment J; Ilan Y
    Hepatology; 1999 Mar; 29(3):746-55. PubMed ID: 10051476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BETA-PROPIOLACTONE PLUS ULTRAVIOLET IRRADIATED PLASMA. A CLINICAL EVALUATION FOR HEPATITIS, TOXICITY AND ALLERGY.
    WOLFRAM BR; LOGRIPPO GA
    Bibl Haematol; 1964; 19():644-7. PubMed ID: 14267084
    [No Abstract]   [Full Text] [Related]  

  • 8. On the mutagenicity and immunogenicity of a beta-propiolactone-treated therapeutic IgG-preparation.
    Pincus JH; Mortelmans K; Tanaka W; Stephan W; Lissner R
    Arzneimittelforschung; 1981; 31(11):1924-8. PubMed ID: 6172136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the effect of betapropiolactone/ultraviolet irradiation (BPL/UV) treatment of source plasma on hepatitis transmission by factor IX complex in chimpanzees.
    Prince AM; Stephan W; Brotman B; van den Ende MC
    Thromb Haemost; 1980 Dec; 44(3):138-42. PubMed ID: 7466740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of the hepatitis safety of a beta-propiolactone/ultraviolet treated factor IX concentrate (PPSB).
    Heinrich D; Kotitschke R; Berthold H
    Thromb Res; 1982 Oct; 28(1):75-83. PubMed ID: 7157232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of combined treatment of serum containing hepatitis B virus with beta-propiolactone and ultraviolet irradiation.
    Stephan W; Berthold H; Prince AM
    Vox Sang; 1981 Sep; 41(3):134-8. PubMed ID: 7331286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of IL-12 on immune suppression and suppressor cell induction by ultraviolet radiation.
    Schmitt DA; Owen-Schaub L; Ullrich SE
    J Immunol; 1995 May; 154(10):5114-20. PubMed ID: 7730617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression.
    Shreedhar V; Giese T; Sung VW; Ullrich SE
    J Immunol; 1998 Apr; 160(8):3783-9. PubMed ID: 9558081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Biotest position on HIV-1 seroconversions in 1990 in 11 patients, treated with beta-propiolactone/uv virus inactivated PPSB].
    Pustoslemsek P; Kloft M; Kotitschke R
    Infusionsther Transfusionsmed; 1993 Dec; 20(6):344-6. PubMed ID: 8142739
    [No Abstract]   [Full Text] [Related]  

  • 15. Active induction of unresponsiveness (tolerance) to DNFB by in vivo ultraviolet-exposed epidermal cells is dependent upon infiltrating class II MHC+ CD11bbright monocytic/macrophagic cells.
    Hammerberg C; Duraiswamy N; Cooper KD
    J Immunol; 1994 Dec; 153(11):4915-24. PubMed ID: 7963554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of beta-propiolactone and ultraviolet irradiation for the treatment of viral contamination of canine serum.
    Yoshimura M; Higashihara M; Masu S
    Kitasato Arch Exp Med; 1967 Dec; 40(1):57-67. PubMed ID: 4303329
    [No Abstract]   [Full Text] [Related]  

  • 17. Transfusion of apoptotic beta-cells induces immune tolerance to beta-cell antigens and prevents type 1 diabetes in NOD mice.
    Xia CQ; Peng R; Qiu Y; Annamalai M; Gordon D; Clare-Salzler MJ
    Diabetes; 2007 Aug; 56(8):2116-23. PubMed ID: 17496235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretreatment with portal venous ultraviolet B-irradiated donor alloantigen promotes donor-specific tolerance to rat nerve allografts.
    Genden EM; Mackinnon SE; Yu S; Hunter DA; Flye MW
    Laryngoscope; 2001 Mar; 111(3):439-47. PubMed ID: 11224773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PROPIOLACTONE PLUS ULTRAVIOLET-TREATED PLASMA WITHOUT HEPATITIS. SIX YEARS' EXPERIENCE.
    LOGRIPPO GA; WOLFRAM BR; BRUSH BE
    Arch Surg; 1964 Apr; 88():721-4. PubMed ID: 14107028
    [No Abstract]   [Full Text] [Related]  

  • 20. Inactivation of the Hutchinson strain of non-A, non-B hepatitis virus by combined use of beta-propiolactone and ultraviolet irradiation.
    Prince AM; Stephan W; Dichtelmüller H; Brotman B; Huima T
    J Med Virol; 1985 Jun; 16(2):119-25. PubMed ID: 3925077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.